https://bibbinstruments.com/first-clinical-study-with-endodrill-published/2016-05-13T15:13:36+02:00https://bibbinstruments.com/swedens-super-startup-2016/2016-05-10T15:15:17+02:00https://bibbinstruments.com/bibbinstruments-genomfor-nyemission-och-forstarker-styrelsen-infor-kommersialisering-och-notering-pa-aktietorget/2017-05-03T15:16:27+02:00https://bibbinstruments.com/bibbinstruments-erhaller-ce-markning-for-endodrill-gi-upper-och-inleder-kommersialisering/2017-09-05T22:33:35+02:00https://bibbinstruments.com/bibbinstruments-ab-ar-godkant-for-notering-pa-aktietorget-och-offentliggor-memorandum-infor-kommande-nyemission/2017-09-18T08:55:32+02:00https://bibbinstruments.com/idag-inleds-teckningstiden-i-bibbinstruments-abs-nyemission-infor-planerad-notering-pa-aktietorget/2017-09-21T09:00:40+02:00https://bibbinstruments.com/bibbinstruments-ab-nyemission-infor-planerad-notering-kraftigt-overtecknad/2017-10-10T14:09:33+02:00https://bibbinstruments.com/bibbinstruments-ab-meddelar-etikgodkannande-for-klinisk-studie-med-endodrill-for-tidigare-diagnos-av-lungcancer/2017-10-10T14:12:55+02:00https://bibbinstruments.com/bibbinstruments-ab-anstaller-nordisk-forsaljningschef/2017-10-11T09:55:49+02:00https://bibbinstruments.com/bibbinstruments-ab-annu-en-europeisk-patentansokan-inlamnad/2017-10-16T16:03:19+02:00https://bibbinstruments.com/bibbinstruments-ab-erhaller-patentgodkannande-fran-europeiska-patentverket/2017-10-18T20:05:01+02:00https://bibbinstruments.com/ledning-styrelse-och-strategiska-parter-har-forvarvat-delar-av-lu-holdings-aktieinnehav-i-bibbinstruments/2017-10-26T10:33:13+02:00https://bibbinstruments.com/bibbinstruments-anlitar-dr-charles-walther-som-chief-medical-officer/2017-11-01T13:26:26+01:00https://bibbinstruments.com/bibbinstruments-delarsrapport/2017-11-27T09:10:57+01:00https://bibbinstruments.com/bibbinstruments-erhaller-uppfoljningsorder-fran-befintlig-kund/2017-11-29T08:45:31+01:00https://bibbinstruments.com/bibbinstruments-forstarker-sin-saljorganisation/2018-02-01T13:54:56+01:00https://bibbinstruments.com/bibbinstruments-bokslutskommunike-2017-01-01-2017-12-31/2018-02-27T09:53:38+01:00https://bibbinstruments.com/bibbinstruments-forstarker-ip-portfoljen-for-endodrill-core-needle/2018-04-11T08:53:17+02:00https://bibbinstruments.com/bibbinstruments-har-fatt-fas-1-ansokan-om-projektanslag-pa-05-miljoner-kronor-godkant-av-eus-horizon-2020-for-forstudie-om-endodrill-model-x/2018-04-12T14:02:25+02:00https://bibbinstruments.com/nytt-datum-for-arsstamma-i-bibbinstruments-ab/2018-04-20T14:19:44+02:00https://bibbinstruments.com/bibbinstruments-ab-meddelar-nytt-datum-for-delarsrapport-januari-mars-2018/2018-05-02T09:32:47+02:00https://bibbinstruments.com/bibbinstruments-delarsrapport-2018-01-01-2018-03-31/2018-05-14T09:58:19+02:00https://bibbinstruments.com/bibbinstruments-lanserar-ny-produkt-endodrill-gi-upper-mini/2018-05-14T10:04:42+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab-publ/2018-05-21T08:57:09+02:00https://bibbinstruments.com/bibbinstruments-moter-stort-intresse-pa-gastrodagarna-och-nomineras-till-arets-ipo-2017/2018-05-29T10:08:05+02:00https://bibbinstruments.com/bibbinstruments-ab-publicerar-arsredovisning-for-2017/2018-05-30T09:48:52+02:00https://bibbinstruments.com/flaggning-i-bibbinstruments-ab/2018-06-26T13:27:02+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-i-bibbinstruments-ab-publ/2018-06-21T17:15:06+02:00https://bibbinstruments.com/bibbinstruments-har-genomfort-uppfoljningsrevision-och-upp-gradering-av-kvalitetssystem-iso-134852016/2018-08-03T10:51:23+02:00https://bibbinstruments.com/bibbinstruments-erhaller-patentgodkannande-fran-kinesiska-patentverket/2018-08-22T08:56:47+02:00https://bibbinstruments.com/bibbinstruments-tillkannager-ny-produktstrategi-efter-framgangsrik-utveckling-av-produktkandidaten-endodrill-model-x/2018-08-24T09:21:56+02:00https://bibbinstruments.com/bibbinstruments-halvarsrapport-2018-01-01-2018-06-30/2018-08-27T10:05:50+02:00https://bibbinstruments.com/bibbinstruments-lamnar-in-europeisk-patentansokan-for-biopsi-instrumentet-endodrill-model-x/2018-10-22T11:28:49+02:00https://bibbinstruments.com/bibbinstruments-ab-erhaller-godkannande-for-ce-markning-av-endodrill-core-needle-och-utokar-sin-marknadspotential/2018-11-02T08:34:13+01:00https://bibbinstruments.com/korrigering-bibbinstruments-beslutar-om-foretradesemission-efter-utvecklingsframgangar-med-endodrill-model-x/2018-11-02T10:02:12+01:00https://bibbinstruments.com/kallelse-till-extra-bolagsstamma-i-bibbinstruments-ab-publ/2018-11-02T10:23:10+01:00https://bibbinstruments.com/bibbinstruments-ab-erhaller-godkannande-for-utokad-ce-markning-av-biopsi-instrumentet-endodrill/2018-11-08T09:46:45+01:00https://bibbinstruments.com/kommunike-fran-extra-bolagsstamma-i-bibbinstruments-ab-publ/2018-11-20T17:00:13+01:00https://bibbinstruments.com/delarsrapport-2018-01-01-2018-09-30-bibbinstruments-ab/2018-11-26T10:43:22+01:00https://bibbinstruments.com/bibbinstruments-ab-publ-offentliggor-memorandum-infor-foretradesemissionen/2018-11-27T11:19:40+01:00https://bibbinstruments.com/idag-inleds-teckningstiden-i-bibbinstruments-abs-foretradesemission/2018-11-29T08:54:05+01:00https://bibbinstruments.com/bibbinstruments-pa-model-x-turne-i-storbritannien-och-pa-irland/2018-12-11T09:32:48+01:00https://bibbinstruments.com/bibbinstruments-tillfors-216-msek-genom-foretradesemission/2018-12-17T14:00:20+01:00https://bibbinstruments.com/delregistrering-av-foretradesemission/2019-01-16T10:29:14+01:00https://bibbinstruments.com/vd-i-bibbinstruments-ab-forvarvar-aktier-av-lu-holding-ab/2019-01-18T09:55:48+01:00https://bibbinstruments.com/sista-dag-for-handel-med-bta-i-bibbinstruments-ab/2019-01-23T14:51:28+01:00https://bibbinstruments.com/bibbinstruments-ab-riktar-ansprak-mot-garantiatagare/2019-02-08T16:13:05+01:00https://bibbinstruments.com/utvardering-av-kommersiella-endodrill-core-needle-har-inletts-vid-tre-universitetssjukhus/2019-02-14T09:18:20+01:00https://bibbinstruments.com/bokslutskommunike-2018/2019-02-28T15:05:38+01:00https://bibbinstruments.com/bibbinstruments-ab-erhaller-patentgodkannande-fran-patentverket-i-australien/2019-03-05T08:57:46+01:00https://bibbinstruments.com/bibb-erhaller-positivt-omdome-fran-den-forsta-patientutvarderingen-av-biopsiinstrumentet-endodrill-core-needle/2019-03-11T10:26:14+01:00https://bibbinstruments.com/bibbinstruments-produkt-endodrill-core-needle-erhaller-formgivningsskydd-i-kina/2019-03-25T10:10:09+01:00https://bibbinstruments.com/bibbinstruments-produkt-endodrill-core-needle-erhaller-designpatent-i-japan/2019-04-01T08:50:13+02:00https://bibbinstruments.com/nytt-datum-for-arsstamma-i-bibbinstruments-ab-2/2019-04-08T16:49:29+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab/2019-04-09T08:33:08+02:00https://bibbinstruments.com/bibb-publicerar-arsredovisning-for-2018/2019-05-01T09:00:46+02:00https://bibbinstruments.com/2553-2/2019-05-15T09:00:33+02:00https://bibbinstruments.com/bibbinstruments-ab-meddelar-framgangsrika-resultat-fran-preklinisk-studie-med-endodrill-model-x/2019-05-20T11:46:31+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-i-bibbinstruments-ab/2019-05-22T13:59:34+02:00https://bibbinstruments.com/styrelseledamot-semmy-rulf-forvarvar-aktier-i-bibbinstruments-ab/2019-05-28T15:18:49+02:00https://bibbinstruments.com/bibbinstruments-ab-lanserar-biopsiinstrumentet-endodrill-core-needle-i-sverige/2019-06-25T09:34:11+02:00https://bibbinstruments.com/bibbinstruments-genomfor-riktad-nyemission-om-cirka-20-msek/2019-06-28T14:04:30+02:00https://bibbinstruments.com/bibbinstruments-erhaller-patent-i-europa-och-japan/2019-08-21T10:09:38+02:00https://bibbinstruments.com/bibb-publicerar-halvarsrapport-q2-2019/2019-08-27T10:05:21+02:00https://bibbinstruments.com/bibbinstruments-erhaller-strategisk-order-fran-universitetssjukhus-i-storbritannien/2019-09-02T08:58:32+02:00https://bibbinstruments.com/bibbinstruments-lamnar-in-ansokan-for-ce-markning-av-endodrill-model-x/2019-09-05T16:26:33+02:00https://bibbinstruments.com/bibbinstruments-staller-ut-endodrill-core-needle-pa-cirse-kongressen-i-barcelona/2019-09-10T09:23:49+02:00https://bibbinstruments.com/bibbinstruments-ab-meddelar-framgangsrika-resultat-fran-prekliniskt-forsok-ii-med-endodrill-model-x/2019-10-28T08:34:56+01:00https://bibbinstruments.com/bibbinstruments-erhaller-notice-of-allowance-fran-patentverket-i-kanada/2019-10-29T08:54:28+01:00https://bibbinstruments.com/bibbinstruments-ab-publicerar-delarsrapport-q3-2019/2019-11-21T09:33:00+01:00https://bibbinstruments.com/bibbinstruments-ab-meddelar-fokuserad-satsning-pa-det-nya-eldrivna-biopsiinstrumentet-endodrill-model-x/2020-02-04T09:04:49+01:00https://bibbinstruments.com/bibbinstruments-ab-publicerar-bokslutskommunike-for-2019/2020-02-13T08:42:13+01:00https://bibbinstruments.com/arsstamma-och-arsredovisningens-tillganglighet/2020-02-13T10:56:22+01:00https://bibbinstruments.com/bibbinstruments-ab-lakemedelsverket-ger-tillstand-till-klinisk-provning-av-endodrill-model-x/2020-02-14T08:26:50+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2020/2020-05-06T08:58:56+02:00https://bibbinstruments.com/kallelse-till-arsstamma-2020-i-bibbinstruments-ab-publ/2020-05-08T12:06:09+02:00https://bibbinstruments.com/bibb-publicerar-arsredovisning-for-2019/2020-05-21T10:31:18+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-i-bibbinstruments-ab-2/2020-06-11T17:32:53+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-forsta-halvaret-2020/2020-08-28T08:30:26+02:00https://bibbinstruments.com/bibbinstruments-ab-forsta-patienten-undersokt-i-klinisk-studie-med-endodrill-model-x/2020-10-02T08:35:41+02:00https://bibbinstruments.com/bibbinstruments-ab-undersoker-mojligheten-att-anvanda-endodrill-model-x-for-provtagning-av-tumorer-i-urinvagarna/2020-10-09T08:57:22+02:00https://bibbinstruments.com/bibbinstruments-ab-den-andra-studieorten-har-borjat-inkludera-patienter-i-multicenterstudien-med-endodrill-model-x/2020-10-16T08:44:31+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2020/2020-11-13T08:57:47+01:00https://bibbinstruments.com/bibb-tillfors-162-msek-genom-riktad-nyemission/2020-12-02T13:13:15+01:00https://bibbinstruments.com/flaggningsmeddelande-i-bibbinstruments/2020-12-03T09:21:06+01:00https://bibbinstruments.com/riktad-nyemission-registrerad-pa-bolagsverket/2020-12-10T11:51:09+01:00https://bibbinstruments.com/cancerdiagnostikbolaget-bibb-erhaller-marknadsgodkannande-i-europa-for-endodrill-model-x/2020-12-11T09:33:00+01:00https://bibbinstruments.com/nytt-datum-for-publicering-av-bokslutskommunike-2020/2021-01-14T11:12:04+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-bokslutskommunike-for-2020/2021-02-15T08:48:57+01:00https://bibbinstruments.com/cancerdiagnostikbolaget-bibb-publicerar-en-produktvideo-om-nya-endodrill-model-x/2021-03-11T13:05:30+01:00https://bibbinstruments.com/bibbinstruments-ab-endodrill-model-x-och-urinblasecancer-ny-indikation-ny-studie-och-forsta-patienten-inkluderad/2021-03-15T08:43:59+01:00https://bibbinstruments.com/bibbinstruments-ab-storning-i-produktionen-av-endodrill-model-x/2021-04-07T08:52:02+02:00https://bibbinstruments.com/bibbinstruments-ab-inlamnar-en-tredje-internationell-patentansokan-for-endodrill-model-x/2021-04-08T08:29:25+02:00https://bibbinstruments.com/kallelse-till-arsstamma-2021-i-bibbinstruments-ab-publ/2021-05-10T15:45:57+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2021/2021-05-12T09:01:51+02:00https://bibbinstruments.com/bibbinstruments-ab-kliniska-studier-med-endodrill-model-x-aterupptas-efter-leverantorsbyte/2021-05-19T13:45:42+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-arsredovisning-for-2020/2021-05-21T08:51:00+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-2021-i-bibbinstruments-ab-publ/2021-06-14T13:21:12+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-forsta-halvaret-2021/2021-08-26T08:43:56+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2021/2021-11-11T09:11:59+01:00https://bibbinstruments.com/bibbinstruments-ab-klinisk-studie-edmx01-med-endodrill-model-x-avslutas-i-fortid-efter-goda-resultat/2021-11-24T08:45:59+01:00https://bibbinstruments.com/bibbinstruments-lamnar-in-ansokan-for-eus-nya-forordning-mdr/2021-12-23T11:08:58+01:00https://bibbinstruments.com/bibb-har-genomfort-en-riktad-nyemission-om-ca-216-msek/2022-02-08T08:52:25+01:00https://bibbinstruments.com/rattelse-bibb-har-genomfort-en-riktad-nyemission-om-ca-216-msek/2022-02-08T11:17:59+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-bokslutskommunike-for-2021/2022-02-11T08:44:05+01:00https://bibbinstruments.com/pilotstudie-med-endodrill-utvald-att-presenteras-pa-digestive-disease-week-ddw/2022-02-18T09:55:18+01:00https://bibbinstruments.com/flaggningsmeddelande-i-bibbinstruments-ab/2022-03-22T14:13:10+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2022/2022-05-06T09:33:31+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab-publ-2/2022-05-06T12:02:51+02:00https://bibbinstruments.com/se-vd-fredrik-lindblads-presentation-pa-aktiedagen-i-goteborg-den-16-maj-2022/2022-05-17T15:39:20+02:00https://bibbinstruments.com/se-vd-fredrik-lindblads-hisspitch-i-maj-2022/2022-05-18T16:21:34+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-arsredovisning-for-2021/2022-05-20T08:51:06+02:00https://bibbinstruments.com/lyckade-presentationer-av-endodrill-vid-digestive-disease-week-ddw-i-san-diego/2022-06-02T09:44:30+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-2022-i-bibbinstruments-ab-publ/2022-06-14T09:59:35+02:00https://bibbinstruments.com/tydlig-vag-for-marknadsgodkannande-i-usa-for-endodrill-efter-uppfoljande-moten-med-fda/2022-06-17T08:59:15+02:00https://bibbinstruments.com/bibbinstruments-ab-klinisk-studie-edux02-med-endodrill-uro-har-avslutats/2022-07-13T10:40:56+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-andra-kvartalet-och-forsta-halvaret-2022/2022-08-26T08:55:49+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2022/2022-11-11T10:22:14+01:00https://bibbinstruments.com/bibb-erhaller-forhandsbesked-om-patentgodkannande-for-eldrivna-endodrill-i-europa/2023-01-05T09:00:04+01:00https://bibbinstruments.com/bibbinstruments-ab-publicerar-bokslutskommunike-for-2022/2023-02-10T09:12:21+01:00https://bibbinstruments.com/bibb-erhaller-ytterligare-ett-forhandsbesked-om-patentgodkannande-for-endodrill-i-europa/2023-03-07T10:31:28+01:00https://bibbinstruments.com/bibb-erhaller-marknadsgodkannande-for-endodrill-gi-pa-den-amerikanska-marknaden/2023-03-30T14:05:42+02:00https://bibbinstruments.com/flaggningsmeddelande-i-bibbinstruments-2/2023-04-03T15:51:03+02:00https://bibbinstruments.com/bibb-informerar-om-status-for-ce-markningsprocessen-enligt-mdr/2023-04-18T09:27:35+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2023/2023-05-04T12:22:17+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab-publ-3/2023-12-18T10:15:07+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-arsredovisning-for-helaret-2022/2023-12-18T10:14:49+01:00https://bibbinstruments.com/bibb-genomfor-en-riktad-nyemission-om-ca-10-msek/2023-12-18T10:14:19+01:00https://bibbinstruments.com/bibb-rapporterar-positiva-resultat-fran-klinisk-pilotstudie-med-endodrill-uro/2023-12-19T08:55:02+01:00https://bibbinstruments.com/flaggning-i-bibbinstruments-ab-med-anledning-av-registrerad-nyemission/2023-12-18T10:13:51+01:00https://bibbinstruments.com/kommunike-fran-arsstamma-i-bibbinstruments-ab-publ-2/2023-12-18T10:13:37+01:00https://bibbinstruments.com/beslutad-tilldelning-avseende-langsiktigt-incitamentsprogram/2023-12-18T10:13:23+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-forsta-halvaret-och-andra-kvartalet-2023/2023-12-18T10:13:05+01:00https://bibbinstruments.com/bibb-erhaller-tva-patent-i-europa-for-endodrill/2024-02-12T10:28:10+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2023/2024-02-12T10:27:50+01:00https://bibbinstruments.com/forsta-kliniska-fallen-i-usa-framgangsrikt-genomforda-med-endodrill-gi/2024-02-12T10:27:31+01:00https://bibbinstruments.com/bibb-erhaller-ce-godkannande-enligt-mdr-i-europa-for-hela-produktfamiljen-endodrill/2024-02-12T10:27:03+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-bokslutskommunike-for-2023/2024-02-12T10:25:50+01:00https://bibbinstruments.com/bibb-lanserar-ny-hemsida/2024-02-13T16:59:29+01:00https://bibbinstruments.com/uc-davis-health-rapporterar-om-positiva-kliniska-erfarenheter-av-endodrill-gi/2024-02-15T10:13:11+01:00https://bibbinstruments.com/det-japanska-patentverket-avser-bevilja-patent-for-endodrill-teknologin/2024-02-21T16:14:23+01:00https://bibbinstruments.com/forsta-kliniska-fallen-med-endodrill-gi-framgangsrikt-genomforda-pa-karolinska-universitetssjukhuset-i-sverige/2024-04-05T11:16:10+02:00https://bibbinstruments.com/framgangsrik-klinisk-pilotstudie-med-endodrill-gi-publicerad-i-expertgranskad-vetenskaplig-tidskrift/2024-04-17T13:09:36+02:00https://bibbinstruments.com/bibb-erhaller-patent-for-endodrill-i-indien/2024-04-18T11:38:29+02:00https://bibbinstruments.com/endodrill-presenteras-som-new-kid-on-the-block-pa-esge-days/2024-04-30T11:32:10+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2024/2024-05-03T10:13:42+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab-publ-4/2024-05-13T17:34:29+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-arsredovisning-for-helaret-2023/2024-05-14T09:46:13+02:00https://bibbinstruments.com/framgangsrika-fallstudier-med-endodrill-gi-fortsatter-i-norge-och-sverige/2024-05-17T11:07:56+02:00https://bibbinstruments.com/bibbinstruments-ab-genomfor-en-riktad-nyemission-om-100-msek/2024-05-20T16:22:22+02:00https://bibbinstruments.com/flaggning-i-bibbinstruments-ab-med-anledning-av-registrerad-nyemission-2/2024-06-04T09:42:59+02:00https://bibbinstruments.com/endodrill-benamns-som-en-lovande-ny-produkt-for-att-losa-ett-betydande-kliniskt-problem-i-medicinsk-tidskrift/2024-06-04T13:35:19+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-i-bibbinstruments-ab-publ-3/2024-08-22T15:14:27+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-forsta-halvaret-2024/2024-11-20T17:30:05+01:00https://bibbinstruments.com/framgangsrik-introduktion-av-endodrill-gi-pa-universitetssjukhuset-sestre-milosrdnice-i-zagreb-kroatien/2024-11-20T17:43:53+01:00https://bibbinstruments.com/bibb-erhaller-forhandsbesked-om-patentgodkannande-for-endodrill-i-europa/2024-11-20T17:43:17+01:00https://bibbinstruments.com/endodrill-gi-vacker-intresse-pa-7th-nordic-eus-meeting-i-kopenhamn/2024-11-20T17:37:38+01:00https://bibbinstruments.com/ny-peer-reviewed-klinisk-fallserie-i-usa-visar-100-diagnostisk-noggrannhet-med-endodrill-gi/2024-11-20T17:38:15+01:00https://bibbinstruments.com/bibb-erhaller-forhandsbesked-om-patentgodkannande-for-endodrill-i-kina/2024-11-20T17:44:47+01:00https://bibbinstruments.com/imponerande-klinisk-fallserie-fran-usa-presenterad-pa-acg-2024-i-philadelphia/2024-11-20T17:40:43+01:00https://bibbinstruments.com/bibb-har-inlett-ett-samarbete-med-svenska-kontraktstillverkaren-cenova/2024-11-20T17:33:53+01:00https://bibbinstruments.com/lyckad-klinisk-introduktion-av-endodrill-gi-pa-sahlgrenska-universitetssjukhuset-i-sverige/2024-11-20T17:39:10+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2024/2024-11-21T11:25:31+01:00https://bibbinstruments.com/kallelse-till-extra-bolagsstamma-i-bibbinstruments-ab/2024-11-20T18:07:38+01:00https://bibbinstruments.com/bibbinstruments-genomfor-en-foretradesemission-av-units-om-cirka-365-msek-avser-uppta-brygglan-om-totalt-30-msek-och-senarelagger-publicering-av-bokslutskommunike/2024-11-20T18:35:47+01:00https://bibbinstruments.com/klinisk-utvardering-pa-karolinska-universitetssjukhuset-fortskrider/2024-11-25T11:36:58+01:00https://bibbinstruments.com/kommunike-fran-extra-bolagsstamma-i-bibbinstruments-ab-den-18-december-2024/2024-12-18T17:08:11+01:00https://bibbinstruments.com/bibbinstruments-offentliggor-prospekt-med-anledning-av-forestaende-foretradesemission-samt-ingar-avtal-om-teckningsforbindelser-med-styrelseledamoter-och-ledande-befattningshavare/2024-12-19T09:28:39+01:00https://bibbinstruments.com/idag-inleds-teckningsperioden-i-bibbinstruments-foretradesemission/2025-01-07T09:09:25+01:00https://bibbinstruments.com/bibbinstruments-offentliggor-preliminart-utfall-i-foretradesemission/2025-01-21T18:04:41+01:00https://bibbinstruments.com/bibbinstruments-offentliggor-slutligt-utfall-i-foretradesemission/2025-01-22T19:05:36+01:00https://bibbinstruments.com/bibb-erhaller-forsta-ordern-pa-endodrill-gi-fran-ett-universitetssjukhus-i-usa/2025-01-24T14:13:37+01:00https://bibbinstruments.com/bibbinstruments-meddelar-forsta-handelsdag-for-teckningsoptioner-serie-to-1/2025-01-31T16:28:57+01:00https://bibbinstruments.com/bibb-deltog-vid-patientfall-med-endodrill-gi-i-tyskland-for-indikationen-eus-leverbiopsi/2025-02-12T11:24:11+01:00https://bibbinstruments.com/forsta-leverfallen-med-endodrill-gi-genomforda-i-usa/2025-02-21T09:13:33+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-bokslutskommunike-for-2024/2025-02-28T08:43:28+01:00https://bibbinstruments.com/framgangsrikt-direktsant-patientfall-med-endodrill-gi-i-porto-portugal/2025-03-18T09:09:47+01:00https://bibbinstruments.com/bibb-erhaller-besked-om-ytterligare-patentgodkannande-for-endodrill-i-kina/2025-04-07T13:03:26+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-forsta-kvartalet-2025/2025-04-29T10:18:00+02:00https://bibbinstruments.com/bibb-och-taewoong-medical-usa-tecknar-letter-of-intent-om-kommersialisering-av-endodrill-gi-i-usa/2025-05-02T18:02:28+02:00https://bibbinstruments.com/kallelse-till-arsstamma-i-bibbinstruments-ab-publ-5/2025-05-13T08:41:28+02:00https://bibbinstruments.com/bibb-erhaller-patentgodkannande-for-endodrill-i-usa/2025-05-15T12:13:15+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-arsredovisning-for-helaret-2024/2025-05-15T16:06:47+02:00https://bibbinstruments.com/bibbinstruments-ab-teckningskursen-for-teckningsoptioner-av-serie-to-1-faststalld-till-325-sek-per-aktie/2025-05-19T11:01:43+02:00https://bibbinstruments.com/bibbinstruments-ab-inlosenperioden-for-teckningsoptioner-av-serie-to-1-inleds-idag/2025-05-21T16:25:18+02:00https://bibbinstruments.com/bibbinstruments-ab-publicerar-ett-brev-fran-vd-fredrik-lindblad/2025-05-22T09:09:49+02:00https://bibbinstruments.com/bibbinstruments-ab-erhaller-avsiktsforklaringar-avseende-teckningsoptioner-av-serie-to-1-fran-ledning-och-styrelseledamoter/2025-05-29T21:13:14+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-utfallet-av-inlosenperioden-for-teckningsoptioner-av-serie-to-1/2025-06-09T15:33:32+02:00https://bibbinstruments.com/kommunike-fran-arsstamma-2025-i-bibbinstruments-ab-publ/2025-06-13T16:30:11+02:00https://bibbinstruments.com/bibbinstruments-meddelar-datum-for-omvandling-av-utnyttjade-teckningsoptioner-av-serie-to-1-till-aktier/2025-06-18T14:07:53+02:00https://bibbinstruments.com/beslut-om-beviljande-av-det-tredje-endodrill-patentet-i-japan/2025-06-24T13:15:28+02:00https://bibbinstruments.com/bibb-ingar-exklusivt-distributionsavtal-med-taewoong-medical-usa/2025-08-04T11:17:37+02:00https://bibbinstruments.com/henry-ford-st-john-hospital-presenterar-de-forsta-amerikanska-leverfallen-med-endodrill-gi/2025-10-10T10:59:40+02:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-halvarsrapport-for-forsta-halvaret-2025/2025-08-21T11:23:07+02:00https://bibbinstruments.com/bibb-engagerar-eus-pionjaren-professor-peter-vilmann-som-vetenskaplig-radgivare/2025-10-10T10:59:20+02:00https://bibbinstruments.com/tidiga-resultat-fran-mayo-clinic-visar-potential-for-endodrill-gi-i-vavnadsodlingsbaserad-pankreascancerforskning/2025-09-09T11:29:42+02:00https://bibbinstruments.com/endodrill-gi-har-nu-officiellt-lanserats-i-usa/2025-10-28T08:09:35+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-delarsrapport-for-tredje-kvartalet-2025/2025-11-07T09:11:02+01:00https://bibbinstruments.com/usa-turne-hosten-2025-bibb-starker-sin-narvaro-pa-den-amerikanska-marknaden/2025-12-03T11:23:26+01:00https://bibbinstruments.com/bibbinstruments-erhaller-fler-ordrar-pa-endodrill-gi-fran-usa/2025-12-17T11:43:22+01:00https://bibbinstruments.com/bibbinstruments-informerar-om-styrelsens-avsikt-att-besluta-om-en-foretradesemission-om-cirka-60-msek/2026-02-09T18:53:02+01:00https://bibbinstruments.com/bibbinstruments-ab-offentliggor-bokslutskommunike-for-2025/2026-02-10T16:53:43+01:00https://bibbinstruments.com/kallelse-till-extra-bolagsstamma-i-bibbinstruments-ab-2/2026-02-10T16:53:12+01:00https://bibbinstruments.com/kommunike-fran-extra-bolagsstamma-i-bibbinstruments-ab-den-13-mars-2026/2026-03-13T16:17:39+01:00https://bibbinstruments.com/bibbinstruments-beslutar-om-tidigare-meddelad-foretradesemission-om-cirka-603-msek/2026-03-19T14:43:05+01:00https://bibbinstruments.com/bibbinstruments-ab-publ-offentliggor-informationsdokument-med-anledning-av-foretradesemission/2026-03-25T08:44:25+01:00https://bibbinstruments.com/rattelse-bibbinstruments-ab-publ-offentliggor-uppdaterat-informationsdokument-med-anledning-av-foretradesemission-felaktig-isin-kod-for-aktien/2026-03-25T21:58:51+01:00https://bibbinstruments.com/bibbinstruments-erhaller-ytterligare-teckningsavsikter-i-den-pagaende-foretradesemissionen/2026-04-01T11:28:48+02:00https://bibbinstruments.com/bibbinstruments-offentliggor-utfall-i-foretradesemission/2026-04-15T14:07:32+02:00https://bibbinstruments.com/flaggningsmeddelande-i-bibbinstruments-ab-publ/2026-04-17T15:19:46+02:00